vimarsana.com
Home
Live Updates
Immunology cardiovascular thematic research center
Live Breaking News & Updates on Immunology cardiovascular thematic research center
Bristol Myers Squibb, Repertoire Enters $1.8 Billion Deal to Develop Vaccines for Autoimmune Diseases
The multi-year collaboration aims to develop tolerizing vaccines for up to 3 autoimmune diseases.
Bristol-myers-squibb
,
Francisco-ram
,
Immunology-cardiovascular-thematic-research-center
,
Repertoire-immune-medicines
,
Myers-squibb
,
Cardiovascular-thematic-research-center
,
Torben-straight-nissen
,
Flagship-pioneering
,
Tolerizing-vaccines
,
Autoimmune-disease-vaccines
,
Autoimmune-diseases
,
Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC Platform Technology
SAN DIEGO - Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced a global.
United-states
,
San-diego
,
California
,
Geoffrey-grande
,
Navjot-rai
,
Sarah-boyce
,
Bristol-myers-squibb
,
Francisco-ramirez-valle
,
Avidity-biosciences-inc
,
Exchange-commission
,
Immunology-cardiovascular-thematic-research-center
,
Nasdaq